BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 208764)

  • 21. N-Hydroxylation of arylamides by the rat and guinea pig. Evidence for substrate specificity and participation of cytochrome P1-450.
    Gutmann HR; Bell P
    Biochim Biophys Acta; 1977 Jun; 498(1):229-43. PubMed ID: 884151
    [No Abstract]   [Full Text] [Related]  

  • 22. Localization of alpha-fetoprotein by immunofluorescence in hyperplastic nodules during hepatocarcinogenesis induced by 2-acetylaminofluorene.
    Okita K; Gruenstein M; Klaiber M; Farber E
    Cancer Res; 1974 Oct; 34(10):2758-63. PubMed ID: 4370173
    [No Abstract]   [Full Text] [Related]  

  • 23. Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates.
    Malejka-Giganti D; Rydell RE; Gutmann HR
    Cancer Res; 1977 Jan; 37(1):111-7. PubMed ID: 830400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of human and rat hepatocyte metabolism and mutagenic activation of 2-acetylaminofluorene.
    Rudo K; Meyers WC; Dauterman W; Langenbach R
    Cancer Res; 1987 Nov; 47(22):5861-7. PubMed ID: 2822235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of hepatocytes by subcarcinogenic exposure to n-2-fluorenylacetamide.
    Becker FF
    Cancer Res; 1975 Jul; 35(7):1734-6. PubMed ID: 165882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium.
    Weeks CE; Allaben WT; Louie SC; Lazear EJ; King CM
    Cancer Res; 1978 Mar; 38(3):613-8. PubMed ID: 203386
    [No Abstract]   [Full Text] [Related]  

  • 27. Mutagenic activation of N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide in subcellular fractions from X/Gf mice.
    Reddy TV; Weisburger EK; Thorgeirsson SS
    J Natl Cancer Inst; 1980 Jun; 64(6):1563-9. PubMed ID: 6929392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subnanogram estimation of the proximate carcinogen N-hydryxy-2-fluorenylacetamide by gas-liquid chromatography.
    Razzouk C; Lhoest G; Roberfroid M; Mercier M
    Anal Biochem; 1977 Nov; 83(1):194-203. PubMed ID: 920936
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic controls in precancerous liver: defective control of cholesterol synthesis in rats fed N-2-fluorenylacetamide.
    Horton BJ; Sabine JR
    Eur J Cancer (1965); 1971 Oct; 7(5):459-65. PubMed ID: 4334170
    [No Abstract]   [Full Text] [Related]  

  • 30. Early events during liver carcinogenesis involving two carcinogen:protein complexes.
    Blackburn GR; Andrews JP; Custer RP; Sorof S
    Cancer Res; 1981 Oct; 41(10):4039-49. PubMed ID: 6269733
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolism and activation of 2-acetylaminofluorene in isolated rat hepatocytes.
    Dybing E; Søderlund E; Haug LT; Thorgeirsson SS
    Cancer Res; 1979 Aug; 39(8):3268-75. PubMed ID: 455309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental pattern of 3-methylcholanthrene-inducible mutagenic activation of N-2-fluorenylacetamide, 2-fluorenamine, and 2,4-diaminoanisole in the rabbit.
    Aune T; Dybing E; Thorgeirsson SS
    J Natl Cancer Inst; 1980 Apr; 64(4):765-9. PubMed ID: 6928989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of N-acetoxy- and N-hydroxy-2-acetylaminofluorene to mutagenic and cytotoxic metabolites by V79 Chinese hamster cells.
    Glatt H; Oesch F
    Mutat Res; 1985 Apr; 149(2):265-9. PubMed ID: 3885026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosome patterns in rat hepatocytes during N-2-fluorenylacetamide carcinogenesis.
    Becker FF; Fox RA; Klein KM; Wolman SR
    J Natl Cancer Inst; 1971 Jun; 46(6):1261-9. PubMed ID: 4325934
    [No Abstract]   [Full Text] [Related]  

  • 35. Activation of 2-acetylaminofluorene in the nuclei of rat liver.
    Kawajiri K; Yonekawa H; Hara E; Tagashira Y
    Cancer Res; 1979 Mar; 39(3):1089-93. PubMed ID: 427750
    [No Abstract]   [Full Text] [Related]  

  • 36. Sulfation of N-hydroxy-2-acetylaminofluorene in normal and nodular liver from male Wistar rats.
    Blanck A; Wicksell L; Eriksson LC
    Toxicol Pathol; 1987; 15(1):103-5. PubMed ID: 3576071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deacetylation to 2-aminofluorene as a major initial reaction in the microsomal metabolism of 2-acetylaminofluorene to mutagenic products in preparations from rabbit lung and liver.
    Aune T; Vanderslice RR; Croft JE; Dybing E; Bend JR; Philpot RM
    Cancer Res; 1985 Nov; 45(11 Pt 2):5859-66. PubMed ID: 4053056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing effect of chemicals on production of hyperplastic liver nodules induced by n-2-fluorenylacetamide in hepatectomized rats.
    Ito N; Tatematsu M; Hirose M; Nakanishi K; Murasaki G
    Gan; 1978 Feb; 69(1):143-4. PubMed ID: 416986
    [No Abstract]   [Full Text] [Related]  

  • 39. [Early histochemical markers of hepatocarcinogenesis].
    Vinarchuk MP; Bykorez AI
    Eksp Onkol; 1984; 6(1):11-6. PubMed ID: 6209085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro metabolism and activation of carcinogenic aromatic amines by subcellular fractions of human liver.
    Dybing E; von Bahr C; Aune T; Glaumann H; Levitt DS; Thorgeirsson SS
    Cancer Res; 1979 Oct; 39(10):4206-11. PubMed ID: 476655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.